Which antipsychotic medications are appropriate for a patient with mildly elevated BUN and normal creatinine (mild renal impairment)?

Antipsychotic Selection in Mild Renal Impairment

Most antipsychotics are safe in mild renal impairment (mildly elevated BUN with normal creatinine) because they are primarily hepatically metabolized and excreted in bile, not through the kidneys. 1, 2, 3

Preferred Antipsychotics (No Dose Adjustment Needed)

The following antipsychotics can be used at standard doses in mild renal impairment:

• Aripiprazole - Primarily hepatic metabolism, minimal renal excretion 1, 2
• Olanzapine - Hepatically metabolized, safe in renal impairment 1, 3
• Quetiapine - Hepatic metabolism predominates, though note it carries higher risk of renal complications long-term 4
• Clozapine - Primarily hepatic, though requires standard monitoring 5, 1
• Lurasidone - Hepatically cleared 1
• Ziprasidone - Minimal renal involvement 3

Antipsychotics Requiring Caution

Risperidone and paliperidone require more careful consideration even in mild impairment:

• Risperidone is metabolized to 9-hydroxyrisperidone, which is renally excreted 6
• Active moiety accumulates with declining renal function 6
• Start with lower doses and monitor serum concentrations if available 6
• The pharmacokinetics are influenced by both kidney function and interacting medications (NSAIDs, ACE inhibitors, diuretics) 6

Amisulpride - Predominantly renally excreted; avoid or use reduced doses even in mild impairment 1

Key Clinical Considerations

Monitoring Strategy

Before initiating any antipsychotic in renal impairment:

• Obtain baseline creatinine clearance calculation (not just serum creatinine) 5
• Review all comedications that affect renal function (NSAIDs, ACE inhibitors, ARBs, diuretics) 6
• Check BMI, blood pressure, glucose, and lipids at baseline 5
• Monitor renal function every 3-4 weeks initially, then every 3 months 5

Practical Pitfalls to Avoid

1. Don't rely on serum creatinine alone - Calculate creatinine clearance, as older adults and those with low muscle mass can have "normal" creatinine despite significant renal impairment 7

2. Watch for drug interactions - Patients on cardiovascular medications (ACE inhibitors, diuretics) have altered risperidone pharmacokinetics requiring lower starting doses 6

3. Quetiapine paradox - While hepatically metabolized and technically "safe," quetiapine carries the highest risk of causing both acute kidney injury and chronic kidney disease progression 4. Consider this when selecting for long-term use.

4. Avoid amisulpride - Despite being an effective antipsychotic, its predominant renal excretion makes it unsuitable even in mild impairment 1

Recommended Approach

For new antipsychotic initiation in mild renal impairment:

1. First-line choices: Aripiprazole, olanzapine, or lurasidone (standard dosing)
2. If risperidone is chosen: Start at 50% of standard dose, titrate slowly, monitor closely 6, 2
3. Avoid: Amisulpride
4. Monitor: Renal function every 3-4 weeks for first 3 months, then quarterly 5

The evidence consistently shows that most second-generation antipsychotics are fat-soluble, hepatically metabolized, and not dialyzable, making them generally safe in renal impairment 3. The key is recognizing which specific agents have significant renal excretion pathways (risperidone, paliperidone, amisulpride) and adjusting accordingly.